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Summary Despite considerable progress in understanding tumour development. the law of growth for human tumours is still a matter of
some dispute. In this study, we used large-scale mammography screening trial data to deduce the growth law of primary breast cancer. We
compared the empirical tumour population size distributions of primary breast cancer inferred from these data to the distributions that
correspond to various possible theoretical growth functions. From this. we showed that the data are inconsistent with the exponential, logistic
and Gompertz laws, but support power law growth (exponent = 0.5). This law indicates unbounded growth but with slowing mass-specific
growth rate and doubling time. In the clinical size ranges, it implies a greater decline in the mass-specific growth rate than would be predicted
by the Gompertz law using the accepted parameters. This suggests that large tumours would be less sensitive to cycle-specifictherapies. and
be better treated first by non-cell cycle-specific agents. We discussed the use of our study to estimate the sensitivity of mammography for the
detection of small tumours. For example, we estimated that mammography is about 30% less sensitive in the detection of tumours in the 1 to
1 .5-cm range than it is in detecting larger tumours.
Keywords: breast cancer: mammography screening: cancer growth law: mathematical model
Breast cancer is the most common malignancy in wxomen.
afflicting one in evers ten women in the WNestern World. Recentlv.
the role of tumour grow-th dynamics in determinin- the clinical
course of the disease has been re-emphasized by demonstrating
howx such know-ledge can lead to more efficient treatment proto-
cols (Crow-n. 19971. Large-scale breast cancer screeninc
mammography trials showx that significantly smaller tumours are
detected in screened populations. compared wxith the control. and it
is probable that the disease w-ould be better controlled if smaller
tumours could be detected (Tabar et al. 1992: see also Kimmel and
Flehinger. 1991 and Xu and Prorok. 1997 for theoretical discus-
sions). Nex ertheless. the benefit of screening. especiall in
youncer women (< 50Xyears). still remains somew-hat controv-ersial
(Fletcher et al. 1993: Tabar et al. 1995: see also Flehinger et al.
1993 for lung cancer). As intersal cancer data indicate that not all
prevalent tumours are detected by the screening procedure
lHolmberg et al. 1986 . anv realistic e-aluation ofmammographic
screening efficiency must account for detection sensitix itv. panic-
ularlv for smaller sizes.
In the present w-ork. we employed extensive clinical data from
large mammogaraphv screening trials that should be representatiVe
of the general population. Usinc mathematical tools. we extracted
from these data useful information about breast cancer growth.
Our conclusions. corroborated by recent laboraton-. clinical and
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theoretical studies. may be relevant to s-arious aspects of tumour
detection and control. In particular. >-e demonstrate howx knol-
edge of size-dependent tumour growth rates can help evaluate the
relative sensitivits ofmammography as a function of tumour size.
This mav be useful for determining! the optimal interval betwxeen
subsequent screenings. In addition. our result may suggest wayvs to
improve chemotherapy treatment protocols.
Previous attempts to estimate human breast cancer growth rates
as a function of size were mostly based on those cases in which the
primary tumour can be seen in retrospect in previous mammo-
grams. This type of analysis is confined only to serv limited and.
possiblY. not representatixe groups of patients (Gershon-Cohen et
al. 1963: Heuser et al. 1979: Foumier et al. 1980: Peer et al. 1993:
Spratt et al. 1993). Several putative lawxs for tumour growth hasve
been proposed. based on this tsype of human study and on experi-
ments in animals. Each of these implies different model-specific
dynamics oftumourg2rowth (Mendelsohn. 1963: Laird. 1965: Steel
and Lamerton. 1966: Norton and Simon. 1976: Norton. 1988).
The most commonly used tumour growth model is exponential
growth. in wxhich the cells divide at a constant rate independent of
tumour size and age. A more general equation. which represents a
ven- broad family of grrowth rates (including the exponential). is
the powxer lawx differential equation:
d!
- = k-v
dt
(1)
>-here v denotes the tumour mass. k is a constant of groxxth and
the exponent 3 is an indicator of the tumour's mode of arowth
l(when 3 = 0. the growxth is linear. wxhen 3 = 1 the groxxth is
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exponential. etc.). The solution ofthepowergrowthlaw (equation 1)
for . 1 is given by:
= [kt (l - P) +c' (2)
where c is a constant. Equation 1 was introduced more than three
decades ago by Mendelsohn. and was shown at that time to fit
observed growth curves of experimental animal mammary
tumours (Mendelsohn. 1963: Dethlefsen et al. 1968).
A different school of thought is represented by the sigmoidal
family offunctions. such as the logistic andGompertz growth laws.
In these laws it is assumed that tumoral and/or host constraints
gradually inhibit tumour growth to an asymptotic value.
Illustrated in Figure IA are the growth curves that represent the
power law model. with 5 = 1 (exponential growth) and 0 = 0.5
(parabolic growth). as well as Gompertz growth. The exponential
and Gompertz curves have been plotted using accepted parameters
drawn from the literature (Foumier et al, 1980; Norton. 1988).
Figure lB shows that these models predict remarkably different
time-dependent changes in the mass-specific tumour growth rate.
Determining which function is most suitable for describing
pnmary breast cancer growth is therefore warranted.
METHODS
Calculating the probability that a tumour is detected
before screening
Consider a tumour of size s that would be present in a natural
population with no removals. This tumour in the actual screen
population. might be detected and removed before screening; we
wish to calculate the probabilityp ofthis detection. Let t(v) be the
probability density (with respect to tumour size) that a tumour is
detected at size v. Then the probability of detection before the
tumour reaches size s is:
p=f (y)dy 0
We can estimate the value ofthis integral using the data for the
control population. These data consist ofthe number n, oftumours
detected between sizes vk and vk. for each of the m size cate-
gories. k = 1.2. m. Theprobability density j. in thekt size class
is thus approximately:
nk
g()=n(y - y'
where n = E n is the total number of tumours detected in the
t=l k
control population. The tumour of size s will be on average
approximately in the middle ofits sizecategory k5. Thus. the above
integral can be approximated as:
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FLgure IA Three possible growth pattems of human pnmary t canoer.
For Gomperz growth a = 0.66 and k = 19 (Norton, 1988), which crespond
to a lkritng volume of 3100 ml. Foumier et al (1980), by analysi
consecutive mammograms of 160 breast cancer patients, estimated that the
mean voume doling time of a tumour of 1.7 cm in dIameter (2.6 ml in
volume) is about 7 months. For exponential growth,ftis corresponds to k=
1.2 years-'. For parabolic growth (power law growth with 0 = 0.5, equaton 2),
the parameter k = 1.6 was estmated from the same data. Forall three
models the initial tumourvolume, yo, is held to be a volume of a single cell.
The tumrourvolume was caklcated by assuming that pnmary breast cancer
grows as a spherid. B A semifogarithnc plot of the mass-specific growth
rates vs tunourdiameterfor the discussed growth laws. The same
parameters as in Figure 1a were used
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Theoretical distributions of tumour sizes in populations
The growth rate of solid tumours depends on a multiplicity of
factors. such as vascularity and nutrient supply. interactions with
surrounding tissues. growth factors, regulation ofapoptosis. and so
on. These factors themselves vary with tumour size. Thus, the rate
ofgrowth ofthe tumour can be considered as a function ofsize. To
express this in mathematical terms. let v(t) denote the tumour mass
at time t. Then the tumour will grow according to some differential
equation ofthe form:
dy
=fl ) (3) dt
wherefis some differentiable function ofthe tumour mass v.
We wish to derive the probability density qp (v) that a tumour.
randomly chosen from a certain size range and growing according
to the differential equation (3). is of size v, assuming no removals
due to treatment or death. It will also be assumed that the distribu-
tion of tumors. (p (v). is stationary. i.e. the probability density of
tumours is independent oftime. This is reasonable for populations
that are fairly stable demographically. and forwhich there has been
no 'point event' (such as an acute exposure to radiation or other
carcinogens) that would cause an unusually large number of
tumours to be formed at about the same time.
Consider the population of tumours whose masses lie in the
interval v and v + Av. Tumours are entering this population at the
rate:
dy(p()= )fl )
dt
they are leaving the population at the rate:
q(v + AV)ftV + AV) = )(y + AV) (fl) +f' (V)Av) + O(AV)
Equating these two quantities and rearranging gives:
p(:Y + AV) - p(v) f (V)
t! =-q(v+Av5! R) +o(Av) (4)
so taking the limit as Av - 0 gives the differential equation:
f' (V)
(p'(y)= <l'(A) (5)
Equation 5 has the general solution:
C
AV)
) =- (6)
where C is a constant chosen to normalize the probability density
to one. In the case of power law growth (equation 1).fly) = kv{.
and hence
!P' (V)
= (7) V
Using equation 6. equation 7 becomes
C
V'3~~~~~~~~~~~~~U
Note that as this result does not depend on the tumour growth rate
parameter k. it is valid even when (as is actualy the case) k varies
in the population, provided the distribution of k values is also
stationary.
Gompertz growth satisfies the differential equation:
dy
-=koe !v
dt (9)
where k0 and a are constants. This equation can be transformed
into the autonomous form ofequation 3 withfgiven by:
flAV) =-rv In (v/K) (10)
where K is the limiting size of the tumour and r is a constant
(Edelstein-Keshet. 1988). Inserting this into equation 6 gives:
C
= vln K - nXv)
The logistic differential equation is:
dy _ = rO} (1-K'v)
dtK
(11)
(12)
where ro and Kare constants. representing the intrinsic growth rate
and the limiting size of the tumour respectively. From equation 6
we have:
C
(13) qp(y) = -
The graphs of the theoretical distributions derived in equations 8.
11 and 13 with best fit of the two-county Swedish data are shown
in Figure 2.
RESULTS
We focused our analysis on the size distribution of tumours found
in the first screen of the two-county Swedish mammography trial.
which is one of the largest and most detailed studies of its kind
(Tabar et al, 1992). Other published mammography screening
trials (Thomas et al, 1984; Fagenberg et al. 1985; Burbenne et al.
1992; Peer et al. 1994; de Koning et al. 1995) are less detailed, but
can provide collaborative information about the tumour size distri-
bution (Table 1).
Our first aim was to reconstruct from the two-county Swedish
mammography data the natural tumour size distribution in the
population, i.e. what the size distribution would have been had
there been no removals before the first screen. To this end. we
employed the distribution of tumour sizes at detection in the two-
county Swedish study's large corresponding control group. We
reconstructed the natural tumour size distribution by estimating the
probability, p, that a tumour of a given size category would have
been detected without screening (see Methods). and then divided
the numberof tumours detected by mammography in each category
by I - p. We excluded from the analysis the smallest (< 1 cm) size
category because of reduced mammography sensitivity in small
tumours (Feig et al. 1977: Yaffe et al. 1993). As the probability of
self-detection in the largest size category (> 5 cm) is close to 1.
dividing by 1 - p would produce a number extremely sensitive to
the exact value ofp. and thus be unreliable: therefore. this size cate-
gory was excluded as well (Table 1). We assumedthat in the 1- to 5-
cm range there is little variation in detection sensitivity (with the
possible exception of the 1- to 1.5-cm category). Hence, we took
the probability ofdetection in these size categories as constant.
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Figure 2 The best fit of tthearel density distibubons of tuimour size
(equations 8, 11 and 13) to the recoructed natural disbu estimated
from the two-unty Swedish data (Tabar et al, 1992) (A). Resuls are
presented on a bg-log plot A highly sin linear fit of the data was
obtained with a siope -- = -0.42; (,e = 0.97). The Gonpertz law was fitted
using a liming size of 3100 ml (Norton, 1988). The logistic growth was fitted
usin a limiting size of 1000 ml estirnated by Spratt et al (1993)
nA
Empircal p
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FLgure 3 Estimation of mammography sensitivity in small tumours (0.5-
1.5cm). The fthretical density distrbuto of tumour size (assuming power
law growth, equaion 8) wasfitted to the two-county Swedish data (in the
1.5-5.0cm range) (A) and subsequently was extapolated to te smallest
btmour range. The ratio between the theoretca and the empincal poits can
be readiy converted to the reave probabilty of detecon. The
mammography in the 1-1.5cm range detects at most 70% of te prevaent
bumours. In the 0.5-1 cm range no more Ftan 40% of Fte tumours are
detected. Results are presented on a logog scale
Table 1 Size disrbution of screened, control and reconstruced natural tumnour populatons, obtained from published breast cancerscreening trias. Only the
first screen data fortumnours are used. The probabiliy density (P density for a tumiour between 1 and 5cm in a natural populatio to be found in a particular
size category is estimated. The results of linear regression of the logarinthm of the natural tumour sizedsibutim vsthe logarithm of the relevanttunour
volumes (inear sope-§, and the correspondin ie) arepresented. For those data sets where the numberof data points was not sufficient to perform a
regression analysis, only the linear sbpes were c d
Souwre Tumour No. No. P. le
size(cm)a sreen controc d f line sloe)
Swedish tw>-county (11 year) (Tabar et al, 1992) 0.1-1 100 50 -0.42 0.97
1-1.4 112 107 0.53
1.5-1.9 74 143 0.44
2-2.9 57 216 0.26
3-4.9 24 143 0.13
5+ 15 68
Total 382 727
Swedish two-county (6 years) (Fagerberg et al, 1985) 0-1 87 32 -0.41
1.1-2 79 120 0.48
2.1-5 32 103 0.17
5.1+ 5 17
Total 203 272
Guildford (Thomas et al, 1984) 0-0.5 26 -0.32 0.99
0.6-1.5 17 0.52
1.6-2 9 0.34
2.1-5 15 0.19
5+ 1
Total 68
Netheriands (de Koning et al, 1995) 0-1 549 307 -0.43
1.1-2 834 1248 0.5
2+ 362 2051 0.17
Total 1744 3606
NiTmegen (Peer et al, 1994) 0-1 40 26 -0.54
1.1-2 92 101 0.54
2+ 36 215 0.1
Total 168 342
British Columbia (Burhenne et al, 1992) 0-1 19 -0.38
1.1-2 10 0.47
2+ 5 0.18
Total 34
aTumourdiameters as reported in the sourcearticles. 'Number of detected cancers in the group. cin data setswih nocontrol population, theSwedishcontrol
incidence rates were used. 'P densrty is the reconstucted natural probabity densiy for the tumour populato between 1 and 5cm (0.6 and 5cm in Gildford).
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We compared this empirical distribution with the theoretical
distributions ofprimary tumour volumes corresponding to power.
Gompertz and logistic growth laws (see Methods). Figure 2
displays the best-fit plots of these theoretical distributions to the
reconstructed natural distribution obtained from data of the two-
county Swedish trial (Tabar et al, 1992). The points calculated
from the trial data lie nearly on a straight line with slope -0 =
- 0.42 (r- = 0.97), indicating a power law growth function with
f = 0.42. Note that these data are inconsistent with exponential
growth (power law with 4 = 1). nor are they consistent with
Gompertz or logistic growth laws with the accepted limiting sizes
(Norton. 1988: Spratt et al. 1993). Most of the non-linearity in the
two-county Swedish data is due to the density of the lowest size
category (1-1.5 cm). where the sensitivity of the mammography
may be less than for larger tumours. Excluding this point gives a
slightly higher exponent (1 = 0.53: r' = 0.99). Thus. the evidence
indicates that primary breast cancer growth is parabolic (power
lawgrowth. 1 -0.5).
Verification of the result using indonent screening
tals
We verified our result by using data from other published
mammography screening trials: only studies that contain sufficient
information foranalysis were included. Ouranalysis of these data.
including an earlier report of the same Swedish study discussed
above(Fagerberg et al. 1985).give consistent results: the data in all
cases are compatible with power law growth. with 1 between 0.32
and 0.55 (Table 1). The slopes ofthe UK (Thomas et al, 1984) and
British Columbia (Burhenne et al, 1992) trials (1 = 0.32 and 1 =
0.38) are even more contradictory to the Gompertz law. However.
as these trials did not have their own control groups. they are less
reliable. If Swedish women were more careful about regular self-
examination. there would be more large tumours removed before
screening compared with the British or the British Columbian
studies. In such a case theprobability ofdetection before screening.
p. in thelarger size classes would be overestimatedby the use ofthe
two-county Swedish control. so the slope would be underestimated.
Note that inall the controlled studies the sloperanged between 0.41
and 0.54. It appears. then. that a control group in each screening
trial isimportant for the use ofthistechnique.
DISCUSSION
Our results suggest that tumour size increases approximately as a
quadratic function of time (i.e. parabolic growth). This is slower
than exponential. but without the limiting asymptotic size
suggestedbysigmoidalgrowth models. Parabolic growth indicates
a mass-specific growth rate that declines with the square root of
tumour mass, asopposed to the constantmass-specific growth rate
of exponential growth. Whereas the Gompertz and the logistic
laws also predict a slowing mass-specific growth rate. these
declines, using the parameters estimated in Norton (1988) and
Spratt (1993). are less significant in the clinical size ranges than
those predicted by parabolic growth (Figure 1B). This may imply
that the response of breast cancer to chemotherapy may be
different than would be suggested by the Norton-Simon model
that assumes Gompertz growth (Norton and Simon. 1986).
There is substantial evidence at the cellular level of a decline in
themass-specificgrowth rate as tumours increase in size. Studies of
the cytokinetics of both human breast cancer and experimental
tumours show that the thymidine labeling index (TLI) declines in
larger tumours. indicating that the fraction of cells that are actively
growing is decreasing (Schiffer et al, 1979: Meyer and Coplin.
1988). Recent reports indicate that the vascular density of tumours
may decline with growth (Holmgren et al. 1995). In such a case a
significant fraction of tumour cells that lie too far from a capillary
will be driven to a non-proliferating state orpossibly even to death.
It should be emphasized that our method does not require
knowledge of the absolute sensitivity of detection. Rather. in this
work we made a simple and not unreasonable assumption that the
sensitivity in the 1- to 5-cm size range is approximately constant.
If independent measures of mammography sensitivity could be
obtained [e.g. by comparing with magnetic resonance imaging
(MRI)] it would be possible to use our method for estimating the
tumour growth law for smaller sizecategories.
Alternatively, assuming that the parabolic growth law holds for
the smaller size categories. the result ofthis study can be used for
estimating the relative sensitivity of mammography in smaller
tumours. This can be done by observing the deviation from
linearity in these size categories in the log-log tumour natural size
distribution plot. For example. it appears. by analysing data from
the two-county Swedish trials. that mammography in the 1-1.5 cm
range is about a third less sensitive than forlarger tumours (Figure
3). By extrapolating the regression line to 0.5- to 1-cm range. we
estimated that the relative sensitivity ofmammography in this size
range is about 40% (assuming 1 = 0.42) or about 30% (assuming
1 = 0.53) compared with larger tumours. This type of sensitivity
analysis. combined with the power law for breast cancer growth,
may help determine the optimal time period between screening
mammography.
This study also may have implications for breast cancer cell
kinetic parameter estimation. For instance, the tumour's potential
doubling time and cell loss factor. which may be useful for dose
calculation inradiotherapy. are calculated underthe assumption ofa
constant cell cycle time and an exponential tumour growth. respec-
tively (Steel. 1967. 1989: Bertuzzi et al. 1995). If. as our study
suggests. tumours follow parabolic growth. it would be necessary
instead to estimate the patient-specific growth constant. k (equation
1). which isprobably highly variable (Fourmieret al. 1980).
Alternating chemotherapy regimens. proposed by Goldie and
Coldman for mi imzing the risk of drug resistance (Goldie and
Coldman. 1979). have been the rationale of numerous anti-cancer
protocols for the last 20 years. Our findings may imply an alterna-
tive strategy. If.as ourresults suggest.there is a significant decline
in the percentage of actively dividing cells in large tumours
(Figure 1B). these tumours would be less sensitive to cycle-
specific therapies. Therefore.they may be better treated first with
rather broaderactivity antineoplastic drugs. such as anthracyclines
or alkylating agents. This may be an explanation for the observa-
tion that alternating the non-cell cycle-specific drug. doxorubicin.
with CMF (cyclophosphamide. methotrexate. 5-fluorouracil. the
last two drugs being cell cycle specific) is significantly inferior to
a sequential chemotherapy protocol with doxorubicin as the first
drug for high-risk (i.e. large tumour burden) breast cancer
(Bonadonna et al. 1995).
Ourresults refer to the growth ofuntreated mou only and their
relevance for the growth pattems of tumours under treatment
remains to be investigated. Nevertheless.it is interesting to note that
the relative benefit of accelerated irradiation strategy (Corvo et al.
1995) may be explained in part by our results. Ifirradiated tumours
are subject to a similar power law growth. according to which as
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tumours shrink under ratment theirgrowth fraction increases, then
the latterperiod oftherapy should be more aggressive.
The optimal growth pattems ofinteracting cell assemblies have
recenfly been shown to follow parabolic or other power laws
(Drasdo et al, 1995). These theoretical results corroborate our
analysis of clinical data. and imply that power growth law may
have greater generality than just to mammary tumours. Our very
preliminary analyses of thyroid cancer and renal cell carcinoma
screening data suggest that the growth rate of these tumours may
also follow a power law. More empirical evidence is needed to
assess the universality of power law growth and its usefulness in
the control ofcancer.
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